Sign In
Buy OCX
$3.20
+0 (+0%)
At Close: Sep 16, 2025
Stock Buzzers: Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), OncoCyte Corporation (AMEX:OCX) - Stocks Equity
03:48am, Friday, 11'th Sep 2020
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) with the stream of 0.25% also noticed, India OncoCyte Corporation (AMEX:OCX) encountered a rapid change of 0.74% in the last hour of Thursday’s trading sess
Hooky Stock: Aytu BioScience, Inc. (NASDAQ:AYTU), OncoCyte Corporation (AMEX:OCX) - Stocks Equity
02:10am, Wednesday, 26'th Aug 2020
Aytu BioScience, Inc. (NASDAQ:AYTU) with the stream of 0.83% also noticed, India OncoCyte Corporation (AMEX:OCX) encountered a rapid change of 0.00% in the last hour of Tuesday’s trading session. Ay
Hilly Stock: OncoCyte Corporation (OCX), Moleculin Biotech, Inc. (MBRX) - Stocks Equity
11:06pm, Sunday, 23'rd Aug 2020
OncoCyte Corporation (AMEX:OCX) with the stream of -5.52% also noticed, India Moleculin Biotech, Inc. (NASDAQ:MBRX) encountered a rapid change of -4.18%. OncoCyte Corporation (AMEX:OCX) closed at $1.3
Oncocyte to Participate at Needham Virtual Cancer Diagnostics Conference
08:05pm, Thursday, 13'th Aug 2020
IRVINE, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points ac
Oncocyte to Hold KOL Webinar Highlighting Clinical Data on Its DetermaIO™ Test for Immunotherapy Response Prediction
12:00pm, Tuesday, 11'th Aug 2020
Event to feature Dr. Naoto Ueno, study investigator and medical oncologist at the University of Texas MD Anderson Cancer Center DetermaIO™, a novel and proprietary test, has been found to independe
Whilst it may not be a huge deal, we thought it was good to see that the OncoCyte Corporation (NYSEMKT:OCX) CEO...
OncoCyte (OCX) Reports Q2 Loss, Tops Revenue Estimates
10:45pm, Wednesday, 29'th Jul 2020
OncoCyte (OCX) delivered earnings and revenue surprises of -27.27% and 257.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Oncocyte Corporation's (OCX) CEO Ronnie Andrews on Q2 2020 Results - Earnings Call Transcript
10:31pm, Wednesday, 29'th Jul 2020
Oncocyte Corporation (NYSEMKT:OCX) Q2 2020 Earnings Conference Call July 29, 2020 4:30 PM ET Company Participants Bob Yedid – Managing Director-LifeSci Advisors Ronnie Andrews – President and Chie
Oncocyte Provides Corporate Update and Reports Second Quarter 2020 Financial Results
08:05pm, Wednesday, 29'th Jul 2020
Secured National Medicare Reimbursement for DetermaRx™ Starting August 2020 with Final Medicare LCD from Palmetto GBA and Noridian Healthcare SolutionsInternational Distribution with ProGenetics Exp
Oncocyte to Report Second Quarter 2020 Financial Results on Wednesday, July 29
08:05pm, Monday, 20'th Jul 2020
IRVINE, Calif., July 20, 2020 -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision.
Noridian's decision aligns with Palmetto GBA's final LCD for the test announced in April Compelling clinical evidence on DetermaRx™ drives the establishment of a new class of.
Oncocyte Announces Distribution Agreement with ProGenetics Ltd, Expanding Commercial Availability of DetermaRx™ to Israel
12:00pm, Thursday, 16'th Jul 2020
IRVINE, Calif., July 16, 2020 -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision.
Oncocyte Provides an Update on the Rapid Growth of DetermaRx™ Physician Adoption and Testing Volume
12:00pm, Tuesday, 14'th Jul 2020
Testing volume for DetermaRx™ doubled from Q1 2020 to Q2 2020 despite challenging COVID-19 macroenvironmentIRVINE, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX)
Industry Analysts Just Upgraded Their OncoCyte Corporation (NYSEMKT:OCX) Revenue Forecasts By 14%
02:54pm, Thursday, 02'nd Jul 2020
Celebrations may be in order for OncoCyte Corporation (NYSEMKT:OCX) shareholders, with the analysts delivering a...
